Cargando…
Application of Blood-Based Biomarkers in Human Mild Traumatic Brain Injury
Traumatic Brain Injury (TBI) is a global health concern. The majority of TBI’s are mild, yet our ability to diagnose and treat mild traumatic brain injury (mTBI) is lacking. This deficiency results from a variety of issues including the difficulty in interpreting ambiguous clinically presented sympt...
Autores principales: | Di Battista, Alex P., Rhind, Shawn G., Baker, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640204/ https://www.ncbi.nlm.nih.gov/pubmed/23641234 http://dx.doi.org/10.3389/fneur.2013.00044 |
Ejemplares similares
-
A Kinetic Model for Blood Biomarker Levels After Mild Traumatic Brain Injury
por: Azizi, Sima, et al.
Publicado: (2021) -
Blood Biomarkers in Moderate-To-Severe Traumatic Brain Injury: Potential Utility of a Multi-Marker Approach in Characterizing Outcome
por: Di Battista, Alex P., et al.
Publicado: (2015) -
Examining four blood biomarkers for the detection of acute intracranial abnormalities following mild traumatic brain injury in older adults
por: Iverson, Grant L., et al.
Publicado: (2022) -
Developing Biomarkers of Mild Traumatic Brain Injury: Promise and Progress of CNS-Derived Exosomes
por: Vaughn, Melonie N., et al.
Publicado: (2022) -
Nomogram for predicting traumatic subdural effusion after mild traumatic brain injury
por: Wei, Lichao, et al.
Publicado: (2022)